For the Inventor, By the Inventor

Enter assignee name

Research Triangle Park, NC, United States of America

Glaxo Inc.

USPTO Granted Patents = 56

Forward Citations = 1,884

Loading Chart...

Loading Chart...

82 inventors (with patents filed for the assignee):

Stephen V Frye (6 out of 15 patents)

Terrence P Kenakin (6 out of 6 patents)

Joel E Shaffer (6 out of 6 patents)

4. Paul L Feldman (6 out of 8 patents)

5. Marcus F Brackeen (6 out of 6 patents)

6. Thomas N Wheeler (6 out of 33 patents)

7. John Joseph Partridge (5 out of 46 patents)

8. Rix E Evans (4 out of 4 patents)

9. M Ross Johnson (4 out of 6 patents)

10. Michael Ross Johnson (3 out of 170 patents)

11. Robert A Casper (3 out of 16 patents)

12. Francis Gerard Fang (3 out of 67 patents)

13. Robert Anthony Mook (3 out of 19 patents)

14. Milana Dezube (3 out of 8 patents)

15. John W Lackey (3 out of 3 patents)

Core Competencies:

Aerosol Drug Formulations

Inhalation Device

Dihydropyridine Vasodilators

Cyclic Antitumor Compounds

Analgesic Compounds

Pyridone Nitriles

Medical Capsule Device

Synthesis of Purine Derivatives

Cholecystokinin Modulators

Multi-Dose Dry Powder Inhalation

Safety Closure Mechanisms

56 patents: Sort by Forward Citations

1. 5457098 - 17 .beta.acyl 6 azaandrost-4,6 diazo-4-ene-3-ones (1995-10-10),

2. 5442892 - System for facilitate recycling goods from defective packages on a (1995-08-22),

3. 5426196 - Synthesis of diaryl methanes (1995-06-20),

4. 5421492 - Metered aerosol dispensing apparatus and method of use thereof (1995-06-06),

5. 5415162 - Multi-dose dry powder inhalation device (1995-05-16),

6. 5407687 - Ranitidine solid dosage form (1995-04-18),

7. 5387688 - Intermediates for making analgesic N-phenyl-N-(3-OR.sup.1 (1995-02-07),

8. 5380872 - Modulators of cholecystokinin (1995-01-10),

9. 5376359 - Method of stabilizing aerosol formulations (1994-12-27),

10. 5342947 - Preparation of water soluble camptothecin derivatives (1994-08-30),

11. 5329008 - Synthesis of a 3,4-dihydroxy-1-cyclopentanylpurinone (1994-07-12),

12. 5326760 - Aminobutanoic acid compounds having metalloprotease inhibiting properties (1994-07-05),

13. 5318976 - Cyclic antitumor compounds (1994-06-07),

14. 5318183 - Bottle with insert to reduce effective volume (1994-06-07),

15. 5302589 - Heterocyclic inhibitors of 5-.alpha.-testosterone reductase (1994-04-12),

Glaxo Inc. is a global pharmaceutical company that specializes in researching, developing, and manufacturing a wide range of prescription medicines and vaccines. With over 100 years of experience, Glaxo Inc. strives to improve the health and well-being of individuals worldwide. They are committed to innovation and actively collaborate with healthcare professionals, patients, and partners to address some of the world's most pressing healthcare challenges.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

56 Patents

#9 in Research Triangle Park, NC

#141 in North Carolina

#6,130 in US

#12,351 in the World

Research Triangle Park, NC, United States of America

Glaxo Inc.

Forward Citations = 1,884

82 inventors:

Stephen V Frye (6 out of 15 patents)

Terrence P Kenakin (6 out of 6 patents)

Joel E Shaffer (6 out of 6 patents)

4. Paul L Feldman (6 out of 8 patents)

5. Marcus F Brackeen (6 out of 6 patents)

Please report any incorrect information to support@idiyas.com

Loading…